← Leaderboards
Deborah Hye Spector
University Of California San Diego
$13,137,426
Attributed
$13,496,067
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$13,496,067 · 14
By mechanism
R01$9,468,615 · 3
R21$2,734,818 · 6
R56$1,262,564 · 2
P41$17,070 · 2
R13$13,000 · 1
Top collaborators
- Stephen A Spector1 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Don W. Cleveland$43,935,794
- Vivek Malhotra$5,188,002
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusVirusViralInfectionBaseCellsPathogenesisGenesCongenital AbnormalityInsightRisk FactorsProteinsVascular DiseasesAffectPlayEndothelial CellsCytomegalovirus InfectionsRecombinant VirusResearch PersonnelGene ExpressionMolecularEnvironmentImmunosuppressedPrevent
Grant awards (47)
Zika Virus Pathogenesis and Selective Autophagy Induction to Inhibit Virus Production$193,750
R21 · FY2018 · AI · contact PI
Zika Virus Pathogenesis and Selective Autophagy Induction to Inhibit Virus Production$232,500
R21 · FY2017 · AI · contact PI
Viral Pathogenesis and Atherosclerosis$193,750
R21 · FY2015 · AI · contact PI
Role of CMV in Heart Disease of HIV-Infected Women and Perinatally Infected Youth$717,283
R56 · FY2014 · HL
Biologic Role of Cytomegalovirus in Endothelial Cell Inflammation and Atheroscler$545,281
R56 · FY2014 · AI · contact PI
Viral Pathogenesis and Atherosclerosis$232,500
R21 · FY2014 · AI · contact PI
Disruption of Neural Stem Cell Homeostasis by Cytomegalovirus$191,813
R21 · FY2014 · NS · contact PI
Disruption of Neural Stem Cell Homeostasis by Cytomegalovirus$232,500
R21 · FY2013 · NS · contact PI
Atherosclerosis: Cytomegalovirus, Shear Stress, and Endothelial Cells$184,350
R21 · FY2012 · AI · contact PI
CMV 2012 - combined 4th Congenital Cytomegalovirus Conference and 14th Internatio$13,000
R13 · FY2012 · AI · contact PI
Human Cytomegalovirus Gene Expression$463,881
R01 · FY2011 · CA · contact PI
Atherosclerosis: Cytomegalovirus, Shear Stress, and Endothelial Cells$223,323
R21 · FY2011 · AI · contact PI
Human Cytomegalovirus Gene Expression$483,606
R01 · FY2010 · CA · contact PI
Disabling of the Anaphase Promoting Complex by Human Cytomegalovirus$184,694
R21 · FY2010 · AI · contact PI
Human Cytomegalovirus Gene Expression$479,553
R01 · FY2009 · CA · contact PI
Disabling of the Anaphase Promoting Complex by Human Cytomegalovirus$225,614
R21 · FY2009 · AI · contact PI
Development of a Novel Vaccine Against Herpes Simplex Type 2$218,818
R21 · FY2009 · AI · contact PI
Human Cytomegalovirus Gene Expression$451,817
R01 · FY2008 · CA · contact PI
Development of a Novel Vaccine Against Herpes Simplex Type 2$189,456
R21 · FY2008 · AI · contact PI
Human Cytomegalovirus Gene Expression$449,627
R01 · FY2007 · CA · contact PI
Development of a Cytomegalovirus Vaccine$360,308
R01 · FY2007 · AI · contact PI
Dysregulation of the Cell Cycle by Human Cytomegalovirus$338,691
R01 · FY2007 · CA · contact PI
Development of a Novel Vaccine Against Herpes Simplex Type 2$231,750
R21 · FY2007 · AI · contact PI
Development of a Cytomegalovirus Vaccine$371,070
R01 · FY2006 · AI · contact PI
Dysregulation of the Cell Cycle by Human Cytomegalovirus$348,807
R01 · FY2006 · CA · contact PI
Human Cytomegalovirus Gene Expression$66,713
R01 · FY2006 · CA · contact PI
TRAFFICKING OF CYTOMEGALOVIRUS FROM THE NUCLEAR MEMBRANE TO THE GOLGI$2,039
P41 · FY2006 · RR · contact PI
Human Cytomegalovirus Gene Expression$443,746
R01 · FY2005 · CA
Development of a Cytomegalovirus Vaccine$380,000
R01 · FY2005 · AI
Dysregulation of the Cell Cycle by Human Cytomegalovirus$357,200
R01 · FY2005 · CA
TRAFFICKING OF CYTOMEGALOVIRUS FROM THE NUCLEAR MEMBRANE TO THE GOLGI$2,161
P41 · FY2005 · RR
Human Cytomegalovirus Gene Expression$430,868
R01 · FY2004 · CA
Development of a Cytomegalovirus Vaccine$380,000
R01 · FY2004 · AI
Dysregulation of the Cell Cycle by Human Cytomegalovirus$357,200
R01 · FY2004 · CA
TRAFFICKING OF CYTOMEGALOVIRUS FROM THE NUCLEAR MEMBRANE TO THE GOLGI$12,870
P41 · FY2004 · RR
Human Cytomegalovirus Gene Expression$394,214
R01 · FY2003 · CA
Development of a Cytomegalovirus Vaccine$380,000
R01 · FY2003 · AI
Dysregulation of the Cell Cycle by Human Cytomegalovirus$357,200
R01 · FY2003 · CA
Human Cytomegalovirus Gene Expression$382,780
R01 · FY2002 · CA
DYSREGULATION OF THE CELL CYCLE BY HUMAN CYTOMEGALOVIRUS$296,821
R01 · FY2002 · CA
DYSREGULATION OF THE CELL CYCLE BY HUMAN CYTOMEGALOVIRUS$66,903
R01 · FY2002 · CA
Human Cytomegalovirus Gene Expression$394,918
R01 · FY2001 · CA
DYSREGULATION OF THE CELL CYCLE BY HUMAN CYTOMEGALOVIRUS$290,036
R01 · FY2001 · CA
DYSREGULATION OF THE CELL CYCLE BY HUMAN CYTOMEGALOVIRUS$65,095
R01 · FY2001 · CA
HCMV, CELL-RELATED DNA AND ONCOGENES$331,324
R01 · FY2000 · CA
DYSREGULATION OF THE CELL CYCLE BY HUMAN CYTOMEGALOVIRUS$282,860
R01 · FY2000 · CA
DYSREGULATION OF THE CELL CYCLE BY HUMAN CYTOMEGALOVIRUS$63,377
R01 · FY2000 · CA